Svenska
|
Site map
|
Contact
Home
Company
Products and Pipeline
Partners and distributors
Investors
Press
Contact
Investors
Annual reports
Financial reports
The stock
Investment presentations
Press releases
Financial calendar
Shareholders
Analysts
Corporate governance
CEO interview
Investors
/
The stock
Moberg Pharmas shares have been quoted on the Nasdaq OMX Stock Exchange (Small Cap segment) since 2011.
Contact Investor relations:
Magnus Persson, IR
Phone: +46 733 55 26 01
Email:
magnus.persson@mobergpharma.se
Peter Wolpert, CEO
Phone +46 8 522 307 00
Email:
peter.wolpert@mobergpharma.se
Moberg Pharma AB (publ)
Gustavslundsvägen 42, 5 tr, SE-167 51 Bromma, Sweden
Phone: +46 8 522 30 700
info@mobergpharma.se
site policy
© Moberg Pharma AB 2013